Prof.Dr. Süleyman Alıcı, Tıbbi Onkoloji &İç Hast. Uzmanı
Prof.Dr. Süleyman Alıcı, Tıbbi Onkoloji &İç Hast. Uzmanı
Bahçeşehir Üniv.Tıp Fak.Medicalpark Göztepe Hast.İst.
Verified email at med.bahcesehir.edu.tr
Title
Cited by
Cited by
Year
Anemia in oncology practice: relation to diseases and their therapies
F Tas, Y Eralp, M Basaran, B Sakar, S Alici, A Argon, G Bulutlar, ...
American journal of clinical oncology 25 (4), 371-379, 2002
1442002
Colorectal cancer in young patients: characteristics and outcome
S Alici, NF Aykan, B Sakar, G Bulutlar, E Kaytan, E Topuz
The Tohoku journal of experimental medicine 199 (2), 85-93, 2003
1102003
Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease
F Tas, F Aykan, S Alici, E Kaytan, A Aydiner, E Topuz
American journal of clinical oncology 24 (6), 547-550, 2001
1072001
Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma.
S Alici, S Kaya, M Izmirli, I Tuncer, H Ozbek, H Sayarlioglu
Medical science monitor 12 (5), CR221-CR229, 2006
772006
Yüzüncü Yıl Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Bilim Dalı'na başvuran kanser hastalarının epidemiyolojik değerlendirilmesi
S ALICI, M İzmirli, E Doğan
Türk Onkoloji Dergisi 21 (2), 87-97, 2006
51*2006
Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer
H Dülger, S Alici, MR Ş ekeroǦlu, R Erkog, H Özbek, T Noyan, M Yavuz
International journal of clinical practice 58 (6), 545-549, 2004
462004
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival …
MA Kaplan, A Isikdogan, D Koca, M Kucukoner, O Gumusay, R Yildiz, ...
Breast cancer 21 (6), 677-683, 2014
392014
Incidence of renal insufficiency in cancer patients
E Dogan, M Izmirli, K Ceylan, R Erkoc, H Sayarlioglu, H Begenik, S Alici
Advances in therapy 22 (4), 357-362, 2005
352005
Sağlık davranışlarının geliştirilmesinde yaşantılayarak öğrenme uygulaması
S Ulupınar Alıcı, Ö Sarıkaya
Dokuz Eylül Üniversitesi Hemşirelik Yüksekokulu, 2009
252009
Prognostic factors and COX-2 expression in advanced stage esophageal squamous cell carcinoma
S Alici, S Ugras, I Bayram, M Izmirli
Advances in therapy 23 (5), 672-679, 2006
222006
Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology)
MA Kaplan, A Isikdogan, D Koca, M Kucukoner, O Gumusay, R Yildiz, ...
Oncology 83 (3), 141-150, 2012
212012
Fatal lactic acidosis due to leukemic transformation in a patient with non-Hodgkin’s lymphoma: case report
E Dogan, R Erkoc, H Sayarlioglu, S Alici, I Dilek, O Alici
Advances in therapy 22 (5), 443-446, 2005
212005
Kahramanmaraş Koşullarında Farklı Azot Dozları ile Sıra Üzeri Ekim Mesafelerinin II. Ürün Mısır (Zea mays L.) Bitkisinde Verim, Verim Unsurları ve Bazı Tarımsal Karakterlere Etkisi
S Alıcı
Doktora Tezi). Çukurova Üniv. Fen Bilimleri Enst. Tarla Bitkileri Anabilim …, 2005
202005
Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC)
S Alici, P Saip, Y Eralp, A Aydiner, E Topuz
American journal of clinical oncology 26 (4), 358-362, 2003
202003
Multiple subcutaneous nodular metastases from transitional cell carcinoma of the bladder
AF Atmaca, Z Akbulut, A Demirci, O Belenli, S Alici, DM Balbay
Pathol Oncol Res 13 (1), 70-2, 2007
192007
Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma
K Ali Osman, B Suleyman, O Metin, A Necati, S Alper, O Nuriye Yildirim, ...
Asian Pacific Journal of Cancer Prevention 13 (2), 463-467, 2012
182012
Predictive and prognostic values of BubR1 and synuclein-gamma expression in breast cancer
Y Cirak, Y Furuncuoglu, O Yapicier, S Alici, A Argon
International journal of clinical and experimental pathology 8 (5), 5345, 2015
142015
Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences
BBO Ustaalioglu, OU Unal, N Turan, A Bilici, S Kaya, T Eren, A Ulas, ...
Asian Pacific Journal of Cancer Prevention 14 (11), 6287-6292, 2013
142013
Prognostic factors in localized aggressive non-Hodgkin’s lymphoma
S Alici, SE Bavbek, E Kaytan, Y Eralp, H Onat
American journal of clinical oncology 26 (1), 1-5, 2003
142003
Value of caffeic acid phenethyl ester pretreatment in experimental sepsis model in rats
O Alici, HS Kavakli, C Koca, ND Altintas, M Aydin, S Alici
Mediators of inflammation 2015, 2015
132015
The system can't perform the operation now. Try again later.
Articles 1–20